Immunogenicity
Showing 1 - 25 of 8,992
COVID-19, Influenza, Vaccine Reaction Trial in Seoul, Incheon (Omicron-containing COVID-19 vaccine, influenza vaccine)
Recruiting
- COVID-19
- +3 more
- Omicron-containing COVID-19 vaccine
- influenza vaccine
-
Seoul, Guro-gu, Korea, Republic of
- +1 more
Oct 17, 2023
Pneumococcal Infections Trial in Adelaide (Gamma-PN3, Pneumovax-23, Prevenar-13)
Recruiting
- Pneumococcal Infections
- Gamma-PN3
- +3 more
-
Adelaide, South Australia, AustraliaUniversity of Adelaide
Aug 1, 2023
COVID-19 Trial in Melbourne (EG-COVII)
Recruiting
- COVID-19
- EG-COVII
-
Melbourne, Victoria, AustraliaNucleus Network Pty Ltd- Melbourne
Oct 24, 2023
Immunosuppression, COVID-19 Trial in Madison (NVX-CoV2372)
Not yet recruiting
- Immunosuppression
- COVID-19
- NVX-CoV2372
-
Madison, WisconsinUW School of Medicine and Public Health
Aug 31, 2023
Zoster, Systemic Lupus Erythematosus, Vaccine Reaction Trial in Seoul (Shingrix, Placebo)
Recruiting
- Zoster
- +2 more
- Shingrix
- Placebo
-
Seoul, Korea, Republic ofSeoul National University Hospital
Aug 17, 2023
Botulism Trial in Richmond (rBV A/B)
Not yet recruiting
- Botulism
- rBV A/B
-
Richmond, CaliforniaCalifornia Department of Public Health
Oct 31, 2023
Epidemic Meningitis Trial (MCV4)
Not yet recruiting
- Epidemic Meningitis
- MCV4
- (no location specified)
Jul 5, 2023
Respiratory Syncytial Virus (RSV) Trial in Rochester (RSV vaccine)
Not yet recruiting
- Respiratory Syncytial Virus (RSV)
- RSV vaccine
-
Rochester, New YorkUniversity of Rochester Medical Center
Oct 11, 2023
COVID-19 Trial in Toyoake (EXG-5003, Placebo)
Completed
- COVID-19
- EXG-5003
- Placebo
-
Toyoake, Aichi, JapanFujita Health University Hospital
Jan 24, 2023
SARS-CoV-2 Trial in Chengdu (SARS-CoV-2 mRNA vaccine (RBMRNA), CoronaVac®)
Active, not recruiting
- SARS-CoV-2
- SARS-CoV-2 mRNA vaccine (RBMRNA)
- CoronaVac®
-
Chengdu, Sichuan, ChinaChengdu Xinhua Hospital affiliated to North Sichuan Medical Coll
Jun 12, 2023
Vaccination; Infection, Vaccine Adverse Reaction Trial (Recombinant zoster vaccination)
Not yet recruiting
- Vaccination; Infection
- Vaccine Adverse Reaction
- Recombinant zoster vaccination
- (no location specified)
Jun 9, 2023
Immunogenicity of After Primary Immunization and Booster
Active, not recruiting
- Polio
- no intervention
-
Pingxiang, Jiangxi, ChinaShangli Center for Disease Control and Prevention
Sep 21, 2023
Polio Trial (polio vaccines: nOPV2, bOPV, IPV)
Not yet recruiting
- Polio
- polio vaccines: nOPV2, bOPV, IPV
- (no location specified)
Nov 2, 2023
Gastroenteritis Trial (HIL-214, Placebo)
Not yet recruiting
- Gastroenteritis
- HIL-214
- Placebo
- (no location specified)
Apr 26, 2023
Advanced Solid Tumor Trial in Beijing (LK101 injection)
Recruiting
- Advanced Solid Tumor
- LK101 injection
-
Beijing, Beijing, China
- +1 more
Sep 22, 2023
Hiv Trial (LP-98 injection)
Not yet recruiting
- Hiv
- LP-98 injection
- (no location specified)
Jun 27, 2023
Vaccine-Preventable Diseases, Hepatitis B Trial in Seongnam-si (CVI-HBV-002)
Completed
- Vaccine-Preventable Diseases
- Hepatitis B
- CVI-HBV-002
-
Seongnam-si, Gyeonggi-do, Korea, Republic ofCHA University Bundang Medical Center
Nov 19, 2023
Advanced Solid Tumors Trial in Shanghai (QLS31903)
Recruiting
- Advanced Solid Tumors
-
Shanghai, Shanghai, ChinaFudan Zhongshan Hospital
Apr 20, 2023
Tetanus Trial in Shangqiu (Investigational tetanus vaccine, adsorbed, Control tetanus vaccine, adsorbed)
Recruiting
- Tetanus
- Investigational tetanus vaccine, adsorbed
- Control tetanus vaccine, adsorbed
-
Shangqiu, Henan, ChinaLiangyuan District Center for Disease Control and Prevention
Sep 15, 2023
Hepatitis A Trial (Healive (hepatitis A vacine(human diploid cell), inactivated))
Not yet recruiting
- Hepatitis A
- Healive (hepatitis A vacine(human diploid cell), inactivated)
- (no location specified)
Sep 21, 2023
Two Domestic HPV Vaccines and Imported HPV Vaccines in Women
Not yet recruiting
- HPV Infection
- +2 more
- Follow up
-
Fuzhou, Fujian, ChinaFujian Maternity and Child Health Hospital
Nov 16, 2023
Healthy Volunteers Trial in Shanghai (CMAB007, Xolair)
Completed
- Healthy Volunteers
- CMAB007
- Xolair
-
Shanghai, ChinaShanghai Xuhui Central Hospital
Jun 8, 2023
Diphtheria, Tetanus, Pertussis Trial (DTaP-HepB-IPV-Hib vaccine)
Not yet recruiting
- Diphtheria
- +5 more
- DTaP-HepB-IPV-Hib vaccine
- (no location specified)
Jul 11, 2023
Safety of a Single Dose of COMVIGEN Vaccine, Reactogenicity of a Single Dose of COMVIGEN Vaccine, Immunogenicity of a Single
Not yet recruiting
- Safety of a Single Dose of COMVIGEN Vaccine
- +5 more
- Comvigen (Bivalent, ChulaCov19 BNA159.2)
- BIVALENT Pfizer/BNT vaccine
-
Bangkok, Thailand
- +1 more
Jun 29, 2023